MindMed Reports Second Quarter 2023 Financial Results and Business Highlights | Psychedelic Invest
Mind Medicine Inc. (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its